OR WAIT null SECS
July 01, 2019
The companies will work to develop a liver tissue model for screening the toxicity of drugs.
More than 30 lots of losartan drug products have been recalled due to contaminated API manufactured by Hetero Labs.
Novavax will sell two Maryland-based vaccine development and manufacturing facilities for Catalent’s expanding gene therapy footprint.
June 28, 2019
Three months following his departure from FDA, former commissioner Scott Gottlieb joins Pfizer’s board of directors.
June 25, 2019
In anticipation of the loss of patent exclusivity for Humira, AbbVie makes $63-billion move to acquire Allergan.
June 24, 2019
The biosimilar, Kanjinti, is approved for all indications of Herceptin, which includes treating breast, gastric, and gastroesophogeal cancers.
June 19, 2019
IVERIC bio and Catalent Biologics have entered into a strategic manufacturing agreement for gene therapy product candidates to treat orphan inherited retinal diseases.
Be The Match BioTherapies and TrakCel have announced a collaboration to provide integrated solutions for companies developing cell and gene therapies.
Biotech company Genmab signed an agreement with Johnson & Johson’s Janssen Biotech to develop a monoclonal antibody product using Genmab’s HexaBody technology.
The companies will use emerging data technologies to create a new virtual innovation lab to develop both scientific and commercial solutions.